|
Bacil Pharma Ltd.
|
Ratio Analysis
|
|
|
You can view the
Ratio Analysis
for the last 5 years.
|
Market Cap. (Rs.)
|
56.31 Cr.
|
P/BV
|
2.18
|
Book Value (Rs.)
|
17.99
|
|
52 Week High/Low (Rs.)
|
63/27
|
FV/ML
|
10/1
|
P/E(X)
|
139.61
|
|
Bookclosure
|
27/09/2024
|
EPS (Rs.)
|
0.28
|
Div Yield (%)
|
0.00
|
|
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| | | | | | |
| PER SHARE RATIOS | | | | | |
| | | | | | |
| Basic EPS (Rs.) | 0.64 | -0.10 | -0.17 | -6.55 | -0.41 |
| Diluted EPS (Rs.) | 0.64 | -0.10 | -0.17 | -6.55 | -0.41 |
| Cash EPS (Rs.) | 0.28 | -0.08 | -0.15 | -5.91 | -0.35 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 18.20 | 1.86 | 1.68 | 1.88 | 2.13 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 18.20 | 1.86 | 1.68 | 1.88 | 2.13 |
| PBDIT / Share (Rs.) | 0.29 | -0.08 | -0.15 | -5.91 | -0.35 |
| PBIT / Share (Rs.) | 0.29 | -0.09 | -0.15 | -5.91 | -0.36 |
| PBT / Share (Rs.) | 0.29 | -0.09 | -0.15 | -5.91 | -0.36 |
| Net Profit / Share (Rs.) | 0.28 | -0.09 | -0.15 | -5.91 | -0.36 |
| Return on Networth / Equity (%) | 1.58 | -4.85 | -9.26 | -315.24 | -17.19 |
| Return on Capital Employeed (%) | 1.60 | -4.86 | -9.26 | -315.26 | -17.22 |
| Return On Assets (%) | 1.57 | -4.44 | -9.03 | -303.54 | -5.85 |
| Total Debt / Equity (X) | 0.01 | 0.08 | 0.01 | 0.02 | 0.12 |
| | | | | | |
| LIQUIDITY RATIOS | | | | | |
| | | | | | |
| Current Ratio (X) | 17.21 | 0.46 | 8.19 | 10.63 | 1.04 |
| Quick Ratio (X) | 17.21 | 0.46 | 8.19 | 10.63 | 1.04 |
| | | | | | |
| VALUATION RATIOS | | | | | |
| | | | | | |
| Enterprise Value (Cr.) | 56.67 | 9.61 | 3.57 | 3.54 | 2.11 |
| EV / EBITDA (X) | 138.82 | -168.53 | -35.97 | -0.91 | -9.00 |
| Price / BV (X) | 2.33 | 7.87 | 3.25 | 3.06 | 1.46 |
| EarningsYield | 0.01 | -0.01 | -0.02 | -1.03 | -0.11 |
